Promotion of osteoclast differentiation and activation in spite of impeded osteoblast-lineage differentiation under acidosis: Effects of acidosis on bone metabolism

BioScience Trends

Volumn 7, Issue 1, 2013, Pages 33-41

  Kato, Kohtaro ^a   Morita, Ikuo ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Acid sensing; Acidosis; Bone metabolism; Osteoblast; Osteoclast

Indexed keywords

G PROTEIN COUPLED RECEPTOR; GPR68 PROTEIN, HUMAN; OSTEOCLAST DIFFERENTIATION FACTOR; REACTIVE OXYGEN METABOLITE; TRANSIENT RECEPTOR POTENTIAL CHANNEL;

ACIDOSIS; ANIMAL; CELL DIFFERENTIATION; CELL HYPOXIA; CELL LINEAGE; CYTOLOGY; GENETICS; HUMAN; METABOLISM; MOUSE; OSTEOCLAST; OSTEOLYSIS; PATHOLOGY; PHYSIOLOGY; REVIEW;

ACIDOSIS; ANIMALS; BONE RESORPTION; CELL DIFFERENTIATION; CELL HYPOXIA; CELL LINEAGE; HUMANS; MICE; OSTEOCLASTS; RANK LIGAND; REACTIVE OXYGEN SPECIES; RECEPTORS, G-PROTEIN-COUPLED; TRANSIENT RECEPTOR POTENTIAL CHANNELS;

EID: 84875917010     PISSN: 18817815     EISSN: 18817823     Source Type: Journal    
DOI: 10.5582/bst.2013.v7.1.33     Document Type: Review

References (56)

1. Arnett TR. Extracellular pH regulates bone cell function. J Nutr. 2008; 138:415S-418S.
2. Buclin T, Cosma M, Appenzeller M, Jacquet AF, Décosterd LA, Biollaz J, Burckhardt P. Diet acids and alkalis influence calcium retention in bone. Osteoporos Int. 2001; 12:493-499.
3. Meghji S, Morrison MS, Henderson B, Arnett TR. pH dependence of bone resorption: mouse calvarial osteoclasts are activated by acidosis. Am J Physiol Endocrinol Metab. 2001; 280:E112-119.
4. Brahimi-Horn MC, Chiche J, Pouysségur J. Hypoxia signalling controls metabolic demand. Curr Opin Cell Biol. 2007; 19:223-229.
5. Orsatti MB, Fucci LL, Valenti JL, Puche RC. Effect of bicarbonate feeding on immobilization osteoporosis in the rat. Calcif Tissue Res. 1976; 21:195-205.
6. Abu Damir H, Scott D, Loveridge N, Buchan W, Milne J. The effects of feeding diets containing either NaHCO3 or NH4Cl on indices of bone formation and resorption and on mineral balance in the lamb. Exp Physiol. 1991; 76:725-732.
7. Schoppen S, Pérez-Granados AM, Carbajal A, Oubiña P, Sánchez-Muniz FJ, Gómez-Gerique JA, Vaquero MP. A sodium-rich carbonated mineral water reduces cardiovascular risk in postmenopausal women. J Nutr. 2004; 134:1058-1063.
8. Frick KK, Bushinsky DA. Metabolic acidosis stimulates RANKL RNA expression in bone through a cyclo-oxygenase-dependent mechanism. J Bone Miner Res. 2003; 18:1317-1325.
9. Komarova SV, Pereverzev A, Shum JW, Sims SM, Dixon SJ. Convergent signaling by acidosis and receptor activator of NF-κB ligand (RANKL) on the calcium/calcineurin/NFAT pathway in osteoclasts. Proc Natl Acad Sci U S A. 2005; 102:2643-2648.
10. Fujita D, Yamashita N, Iita S, Amano H, Yamada S, Sakamoto K. Prostaglandin E2 induced the differentiation of osteoclasts in mouse osteoblast-depleted bone marrow cells. Prostaglandins, Leukotrienes and Essential Fatty Acids. 2003; 68:351-358.
11. Hoenderop JG, van Leeuwen JP, van der Eerden BC, Kersten FF, van der Kemp AW, Mérillat AM, Waarsing JH, Rossier BC, Vallon V, Hummler E, Bindels RJ. Renal Ca2+ wasting, hyperabsorption, and reduced bone thickness in mice lacking TRPV5. J Clin Invest. 2003; 112:1906-1914.
12. Chamoux E, Bisson M, Payet MD, Roux S. TRPV-5 mediates a receptor activator of NF-κB (RANK) ligand-induced increase in cytosolic Ca2+ in human osteoclasts and down-regulates bone resorption. J Biol Chem. 2010; 285:25354-25362.
13. Muzylak M, Arnett TR, Price JS, Horton MA. The in vitro effect of pH on osteoclasts and bone resorption in the cat: implications for the pathogenesis of FORL. J Cell Physiol. 2007; 213:144-150.
14. Teramoto T. The effect of extracellular pH on the adherence and differentiation of isolated rat osteoclasts. Jpn J Oral Biol. 1998; 40:62-72.
15. Kato K, Morita I. Acidosis environment promotes osteoclast formation by acting on the last phase of preosteoclast differentiation: a study to elucidate the action points of acidosis and search for putative target molecules. Eur J Pharmacol. 2011; 663:27-39.
16. Ludwig MG, Vanek M, Guerini D, Gasser JA, Jones CE, Junker U, Hofstetter H, Wolf RM, Seuwen K. Proton-sensing G-protein-coupled receptors. Nature. 2003; 425:93-98.
17. Yang M, Mailhot G, Birnbaum MJ, MacKay CA, Mason-Savas A, Odgren PR. Expression of and role for ovarian cancer G-protein-coupled receptor 1 (OGR1) during osteoclastogenesis. J Biol Chem. 2006; 281:23598-23605.
18. Tomura H, Mogi C, Sato K, Okajima F. Proton-sensing and lysolipid-sensitive G-protein-coupled receptors: a novel type of multi-functional receptors. Cell Signal. 2005; 17:1466-1476.
19. Everaerts W, Nilius B, Owsianik G. The vanilloid transient receptor potential channel TRPV4: from structure to disease. Prog Biophys Mol Biol. 2010; 103:2-17.
20. Vriens J, Appendino G, Nilius B. Pharmacology of vanilloid transient receptor potential cation channels. Mol Pharmacol. 2009; 75:1262-1279.
21. Deval E, Gasull X, Noël J, Salinas M, Baron A, Diochot S, Lingueglia E. Acid-sensing ion channels (ASICs): pharmacology and implication in pain. Pharmacol Ther. 2010; 128:549-558.
22. Rossi F, Siniscalco D, Luongo L, De Petrocellis L, Bellini G, Petrosino S, Torella M, Santoro C, Nobili B, Perrotta S, Di Marzo V, Maione S. The endovanilloid/endocannabinoid system in human osteoclasts: possible involvement in bone formation and resorption. Bone. 2009; 44:476-484.
23. Idris AI, Landao-Bassonga E, Ralston SH. The TRPV1 ion channel antagonist capsazepine inhibits osteoclast and osteoblast differentiation in vitro and ovariectomy induced bone loss in vivo. Bone. 2010; 46:1089-1099.
24. Inoue R, Jian Z, Kawarabayashi Y. Mechanosensitive TRP channels in cardiovascular pathophysiology. Pharmacol Ther. 2009; 123:371-385.
25. Thodeti CK, Matthews B, Ravi, A, Mammoto A, Ghosh K., Bracha AL, Ingber DE. TRPV4 channels mediate cyclic strain-induced endothelial cell reorientation through integrin-to-integrin signaling. Circ Res. 2009; 104:1123-1130.
26. Voets T, Talavera K, Owsianik G, Nilius B. Sensing with TRP channels. Nat Chem Biol. 2005; 1:85-92.
27. Mizoguchi F, Mizuno A, Hayata T, Nakashima K, Heller S, Ushida T, Sokabe M, Miyasaka N, Suzuki M, Ezura Y, Noda M. Transient receptor potential vanilloid 4 deficiency suppresses unloading-induced bone loss. J Cell Physiol. 2008; 216:47-53.
28. Masuyama R, Vriens J, Voets T, Karashima Y, Owsianik G, Vennekens R, Lieben L, Torrekens S, Moermans K, Vanden Bosch A, Bouillon R, Nilius B, Carmeliet G. TRPV4-mediated calcium influx regulates terminal differentiation of osteoclasts. Cell Metab. 2008; 8:257-265.
29. Suzuki M, Mizuno A, Kodaira K, Imai M. Impaired pressure sensation in mice lacking TRPV4. J Biol Chem. 2003; 278:22664-22668.
30. Yamaji Y, Tsuganezawa H, Moe OW, Alpern RJ. Intracellular acidosis activates c-Src. Am J Physiol. 1997; 272:C886-893.
31. Masuyama R, Mizuno A, Komori H, Kajiya H, Uekawa A, Kitaura H, Okabe K, Ohyama K, Komori T. Calcium/calmodulin-signaling supports TRPV4 activation in osteoclasts and regulates bone mass. J Bone Miner Res. 2012; 27:1708-1721.
32. Moriyama T, Higashi T, Togashi K, Iida T, Segi E, Sugimoto Y, Tominaga T, Narumiya S, Tominaga M. Sensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins. Mol Pain 2005; 1:3.
33. Meves H. Arachidonic acid and ion channels: an update. Br J Pharmacol. 2008; 155:4-16.
34. Fleming I, Rueben A, Popp R, Fisslthaler B, Schrodt S, Sander A, Haendeler J, Falck JR, Morisseau C, Hammock BD, Busse R. Epoxyeicosatrienoic acids regulate Trp channel dependent Ca2+ signaling and hyperpolarization in endothelial cells. Arterioscler Thromb Vasc Biol. 2007; 27:2612-2618.
35. Hata AN, Breyer RM. Pharmacology and signaling of prostaglandin receptors: multiple roles in inflammation and immune modulation. Pharmacol Ther. 2004; 103:147-166.
36. Granholm S, Lundberg P, Lerner UH. Calcitonin inhibits osteoclast formation in mouse haematopoetic cells independently of transcriptional regulation by receptor activator of NF-κB and c-Fms. J Endocrinol. 2007; 195:415-427.
37. Kajiya H, Okamoto F, Nemoto T, Kimachi K, Toh-Goto K, Nakayana S, Okabe K. RANKL-induced TRPV2 expression regulates osteoclastogenesis via calcium oscillations. Cell Calcium 2010; 48:260-269.
38. Pereverzev A, Komarova SV, Korcok J, Armstrong S, Tremblay GB, Dixon SJ, Sims SM. Extracellular acidification enhances osteoclast survival through an NFAT-independent, protein kinase C-dependent pathway. Bone. 2008; 42:150-161.
39. Ahn H, Kim JM, Lee K, Kim H, Jeong D. Extracellular acidosis accelerates bone resorption by enhancing osteoclast survival, adhesion, and migration. Biochem Biophys Res Commun. 2012; 418:144-148.
40. Tomura H, Wang JQ, Liu JP, Komachi M, Damirin A, Mogi C, Tobo M, Nochi H, Tamoto K, Im DS, Sato K, Okajima F. Cyclooxygenase-2 expression and prostaglandin E2 production in response to acidic pH through OGR1 in a human osteoblastic cell line. J Bone Miner Res. 2008; 23:1129-1139.
41. Krieger NS, Bushinsky DA. Pharmacological inhibition of intracellular calcium release blocks acid-induced bone resorption. Am J Physiol Renal Physiol. 2011; 300:F91-97.
42. Geng W, Hill K, Zerwekh JE, Kohler T, Müller R, Moe OW. Inhibition of osteoclast formation and function by bicarbonate: role of soluble adenylyl cyclase. J Cell Physiol. 2009; 220:332-340.
43. Brandao-Burch A, Utting JC, Orriss IR, Arnett TR. Acidosis inhibits bone formation by osteoblasts in vitro by preventing mineralization. Calcif Tissue Int. 2005; 77:167-174.
44. Giepmans BN. Gap junctions and connexin-interacting proteins. Cardiovasc Res. 2004; 62:233-245.
45. Lin JH, Yang J, Liu S, Takano T, Wang X, Gao Q, Willecke K, Nedergaard M. Connexin mediates gap junction-independent resistance to cellular injury. J Neurosci. 2003; 23:430-441.
46. Plotkin LI. Connexin43 and bone: not just gap junction protein. Actual osteol. 2011; 7:79-90.
47. Chung DJ, Castro CH, Watkins M, Stains JP, Chung MY, Szejnfeld VL, Willecke K, Theis M, Civitelli R. Low peak bone mass and attenuated anabolic response to parathyroid hormone in mice with an osteoblast-specific deletion of connexin43. J Cell Sci. 2006; 119:4187-4198.
48. Bivi N, Condon KW, Allen MR, Farlow N, Passeri G, Brun LR, Rhee Y, Bellido T, Plotkin LI. Cell autonomous requirement of connexin 43 for osteocyte survival: consequences for endocortical resorption and periosteal bone formation. J Bone Miner Res. 2012; 27:374-389.
49. Zhang Y, Paul EM, Sathyendra V, Davison A, Sharkey N, Bronson S, Srinivasan S, Gross TS, Donahue HJ. Enhanced osteoclastic resorption and responsiveness to mechanical load in gap junction deficient bone. PLoS One. 2011; 6:e23516.
50. Duffy HS, Ashton AW, O'Donnell P, Coombs W, Taffet SM, Delmar M, Spray DC. Regulation of connexin43 protein complexes by intracellular acidification. Circ Res. 2004; 94:215-222.
51. Lecanda F, Warlow PM, Sheikh S, Furlan F, Steinberg TH, Civitelli R. Connexin43 deficiency causes delayed ossification, craniofacial abnormalities, and osteoblast dysfunction. J Cell Biol. 2000; 151:931-944.
52. Danon A, Zeevi-Levin N, Pinkovich DY, Michaeli T, Berkovich A, Flugelman M, Eldar YC, Rosen MR, Binah O. Hypoxia causes connexin 43 internalization in neonatal rat ventricular myocytes. Gen Physiol Biophys. 2010; 29:222-233.
53. Arnett TR. Acidosis, hypoxia and bone. Arch Biochem Biophys. 2010; 503:103-109.
54. Kim MS, Yang YM, Son A, Tian YS, Lee SI, Kang SW, Muallem S, Shin DM. Rankl-mediated reactive oxygen species pathway that induces long lasting Ca2+ oscillations essential for osteoclastogenesis. J Biol Chem. 2010; 285:6913-6921.
55. Almeida M, Han L, Ambrogini E, Weinstein RS, Monolagas SC. Glucocorticids and tumor necrosis factor α increase oxidative stress and suppress wnt protein signaling in osteoblasts. J Biol Chem. 2011; 286:44326-44335.
56. Riemann A, Schneider B, Ihling A, Nowak M, Sauvant C, Thews O, Gekle M. Acidic environment leads to Ros-induced mapk signaling in cancer cells. PLos One. 2011; 6:e22445.